ArticleJournal of gastrointestinal oncology2023

Efficacy, safety, and predictors of fruquintinib plus anti-programmed death receptor-1 (PD-1) antibody in refractory microsatellite stable metastatic colorectal cancer in a real-world setting: a retrospective cohort study.

Xiaolin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.